Acadia Healthcare (NASDAQ: ACHC) is a prominent provider of inpatient behavioral health care services. The company has been recognized for its strong performance in the healthcare sector, particularly in the behavioral health space. Acadia competes with other healthcare providers, but its focus on behavioral health gives it a unique position in the market.
On February 26, 2026, Raymond James maintained its "Outperform" rating for ACHC, with the stock trading at $22.18. This rating suggests confidence in the company's future performance, despite the recommendation to "hold" the stock. The positive outlook is supported by Acadia's recent financial results, which have shown resilience and growth.
In the fourth quarter, Acadia Healthcare reported adjusted earnings of $0.07 per share, significantly exceeding the Zacks Consensus Estimate of $0.03. This represents an earnings surprise of +164.15%. However, it's important to note that this is a decrease from the $0.64 per share reported in the same quarter the previous year. Despite the decline, the company has consistently surpassed consensus EPS estimates in the last four quarters.
Acadia's total revenues for the quarter reached $821.5 million, surpassing the expected $799 million and marking a 6.1% increase year-over-year. This growth was driven by an increase in patient days and admissions, as well as higher revenues per patient day. However, the gains were partially offset by a shorter average length of stay and increased expenses.
Looking ahead, Acadia Healthcare anticipates 2026 revenues to be between $3.37 billion and $3.45 billion, with an adjusted EBITDA ranging from $575 million to $610 million. The company's stock has seen a 23% surge following the announcement of its fourth-quarter and full-year 2025 results, benefiting from a broader market upswing. With a market capitalization of approximately $2 billion, Acadia Healthcare remains a significant player in the behavioral health care sector.
